Stock QNCX QUINCE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Transcripts Quince Therapeutics, Inc.

Equities

QNCX

US22053A1079

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-24 pm EDT 		5-day change 1st Jan Change
0.8499 USD -2.31% Intraday chart for Quince Therapeutics, Inc. -6.09% -19.06%
May. 13 Quince Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 01 Quince Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Transcripts

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Transcript : Quince Therapeutics, Inc. - Special Call
Transcript : Quince Therapeutics, Inc. - Shareholder/Analyst Call
Transcript : Cortexyme, Inc. - Special Call
Transcript : Cortexyme, Inc. Presents at H.C. Wainwright 23rd Annual Global Investment Conference, Sep-13-2021 07:00 AM
Transcript : Cortexyme, Inc. - Special Call
Transcript : Cortexyme, Inc. - Special Call
Transcript : Cortexyme, Inc. Presents at The JMP Securities Life Sciences Conference, Jun-16-2021 03:00 PM
Transcript : Cortexyme, Inc. Presents at Jefferies 2021 Virtual Healthcare Conference, Jun-02-2021 02:00 PM
Transcript : Cortexyme, Inc. Presents at Stifel's 3rd Annual CNS Day, Apr-01-2021 10:00 AM
Transcript : Cortexyme, Inc. Presents at Oppenheimer 31st Annual Healthcare Conference, Mar-16-2021 02:30 PM
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. QNCX Stock
  4. News Quince Therapeutics, Inc.
  5. Transcripts